Sterility Indicators
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Antibiotic Resistance Market Research Report 2023
1 Antibiotic Resistance Market Overview
1.1 Product Overview and Scope of Antibiotic Resistance
1.2 Antibiotic Resistance Segment By Disease
1.2.1 Global Antibiotic Resistance Sales Growth Rate Comparison By Disease (2022-2028)
1.2.2 By Disease
1.2.3 By Pathogen
1.3 Antibiotic Resistance Segment by Application
1.3.1 Global Antibiotic Resistance Sales Comparison by Application: (2022-2028)
1.3.2 Oxazolidinones
1.3.3 Lipoglycopeptides
1.3.4 Tetracyclines
1.3.5 Cephalosporins
1.3.6 Combination therapies
1.3.7 Other
1.4 Global Antibiotic Resistance Market Size Estimates and Forecasts
1.4.1 Global Antibiotic Resistance Revenue 2017-2028
1.4.2 Global Antibiotic Resistance Sales 2017-2028
1.4.3 Antibiotic Resistance Market Size by Region: 2017 Versus 2021 Versus 2028
2 Antibiotic Resistance Market Competition by Manufacturers
2.1 Global Antibiotic Resistance Sales Market Share by Manufacturers (2017-2022)
2.2 Global Antibiotic Resistance Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Antibiotic Resistance Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Antibiotic Resistance Manufacturing Sites, Area Served, Product Type
2.5 Antibiotic Resistance Market Competitive Situation and Trends
2.5.1 Antibiotic Resistance Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibiotic Resistance Players Market Share by Revenue
2.5.3 Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibiotic Resistance Retrospective Market Scenario by Region
3.1 Global Antibiotic Resistance Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Antibiotic Resistance Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Antibiotic Resistance Market Facts & Figures by Country
3.3.1 North America Antibiotic Resistance Sales by Country
3.3.2 North America Antibiotic Resistance Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibiotic Resistance Market Facts & Figures by Country
3.4.1 Europe Antibiotic Resistance Sales by Country
3.4.2 Europe Antibiotic Resistance Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibiotic Resistance Market Facts & Figures by Region
3.5.1 Asia Pacific Antibiotic Resistance Sales by Region
3.5.2 Asia Pacific Antibiotic Resistance Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antibiotic Resistance Market Facts & Figures by Country
3.6.1 Latin America Antibiotic Resistance Sales by Country
3.6.2 Latin America Antibiotic Resistance Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antibiotic Resistance Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibiotic Resistance Sales by Country
3.7.2 Middle East and Africa Antibiotic Resistance Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antibiotic Resistance Historic Market Analysis by Type
4.1 Global Antibiotic Resistance Sales Market Share by Type (2017-2022)
4.2 Global Antibiotic Resistance Revenue Market Share by Type (2017-2022)
4.3 Global Antibiotic Resistance Price by Type (2017-2022)
5 Global Antibiotic Resistance Historic Market Analysis by Application
5.1 Global Antibiotic Resistance Sales Market Share by Application (2017-2022)
5.2 Global Antibiotic Resistance Revenue Market Share by Application (2017-2022)
5.3 Global Antibiotic Resistance Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Allergan Antibiotic Resistance Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 AmpliPhi Biosciences
6.2.1 AmpliPhi Biosciences Corporation Information
6.2.2 AmpliPhi Biosciences Description and Business Overview
6.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AmpliPhi Biosciences Antibiotic Resistance Product Portfolio
6.2.5 AmpliPhi Biosciences Recent Developments/Updates
6.3 BioVersys GmbH
6.3.1 BioVersys GmbH Corporation Information
6.3.2 BioVersys GmbH Description and Business Overview
6.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.3.4 BioVersys GmbH Antibiotic Resistance Product Portfolio
6.3.5 BioVersys GmbH Recent Developments/Updates
6.4 Macrolide Pharmaceuticals
6.4.1 Macrolide Pharmaceuticals Corporation Information
6.4.2 Macrolide Pharmaceuticals Description and Business Overview
6.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Product Portfolio
6.4.5 Macrolide Pharmaceuticals Recent Developments/Updates
6.5 Melinta Therapeutics
6.5.1 Melinta Therapeutics Corporation Information
6.5.2 Melinta Therapeutics Description and Business Overview
6.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Melinta Therapeutics Antibiotic Resistance Product Portfolio
6.5.5 Melinta Therapeutics Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Merck Antibiotic Resistance Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Nabriva Therapeutics
6.6.1 Nabriva Therapeutics Corporation Information
6.6.2 Nabriva Therapeutics Description and Business Overview
6.6.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Nabriva Therapeutics Antibiotic Resistance Product Portfolio
6.7.5 Nabriva Therapeutics Recent Developments/Updates
6.8 Nemesis Bioscience
6.8.1 Nemesis Bioscience Corporation Information
6.8.2 Nemesis Bioscience Description and Business Overview
6.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Nemesis Bioscience Antibiotic Resistance Product Portfolio
6.8.5 Nemesis Bioscience Recent Developments/Updates
6.9 Phage Technologies S.A
6.9.1 Phage Technologies S.A Corporation Information
6.9.2 Phage Technologies S.A Description and Business Overview
6.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Phage Technologies S.A Antibiotic Resistance Product Portfolio
6.9.5 Phage Technologies S.A Recent Developments/Updates
6.10 Tetraphase Pharmaceuticals
6.10.1 Tetraphase Pharmaceuticals Corporation Information
6.10.2 Tetraphase Pharmaceuticals Description and Business Overview
6.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Product Portfolio
6.10.5 Tetraphase Pharmaceuticals Recent Developments/Updates
6.11 The Medicines Company
6.11.1 The Medicines Company Corporation Information
6.11.2 The Medicines Company Antibiotic Resistance Description and Business Overview
6.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.11.4 The Medicines Company Antibiotic Resistance Product Portfolio
6.11.5 The Medicines Company Recent Developments/Updates
6.12 TPfizer
6.12.1 TPfizer Corporation Information
6.12.2 TPfizer Antibiotic Resistance Description and Business Overview
6.12.3 TPfizer Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.12.4 TPfizer Antibiotic Resistance Product Portfolio
6.12.5 TPfizer Recent Developments/Updates
6.13 Westway Health
6.13.1 Westway Health Corporation Information
6.13.2 Westway Health Antibiotic Resistance Description and Business Overview
6.13.3 Westway Health Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Westway Health Antibiotic Resistance Product Portfolio
6.13.5 Westway Health Recent Developments/Updates
7 Antibiotic Resistance Manufacturing Cost Analysis
7.1 Antibiotic Resistance Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibiotic Resistance
7.4 Antibiotic Resistance Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibiotic Resistance Distributors List
8.3 Antibiotic Resistance Customers
9 Antibiotic Resistance Market Dynamics
9.1 Antibiotic Resistance Industry Trends
9.2 Antibiotic Resistance Market Drivers
9.3 Antibiotic Resistance Market Challenges
9.4 Antibiotic Resistance Market Restraints
10 Global Market Forecast
10.1 Antibiotic Resistance Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibiotic Resistance by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Antibiotic Resistance by Type (2023-2028)
10.2 Antibiotic Resistance Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibiotic Resistance by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Antibiotic Resistance by Application (2023-2028)
10.3 Antibiotic Resistance Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibiotic Resistance by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Antibiotic Resistance by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Antibiotic Resistance Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Antibiotic Resistance Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Antibiotic Resistance Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Antibiotic Resistance Market Competitive Situation by Manufacturers in 2021
Table 5. Global Antibiotic Resistance Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Antibiotic Resistance Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Antibiotic Resistance Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Antibiotic Resistance Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Antibiotic Resistance Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Antibiotic Resistance Manufacturing Sites and Area Served
Table 11. Manufacturers Antibiotic Resistance Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibiotic Resistance by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotic Resistance as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antibiotic Resistance Sales by Region (2017-2022) & (K Units)
Table 16. Global Antibiotic Resistance Sales Market Share by Region (2017-2022)
Table 17. Global Antibiotic Resistance Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Antibiotic Resistance Revenue Market Share by Region (2017-2022)
Table 19. North America Antibiotic Resistance Sales by Country (2017-2022) & (K Units)
Table 20. North America Antibiotic Resistance Sales Market Share by Country (2017-2022)
Table 21. North America Antibiotic Resistance Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Antibiotic Resistance Revenue Market Share by Country (2017-2022)
Table 23. Europe Antibiotic Resistance Sales by Country (2017-2022) & (K Units)
Table 24. Europe Antibiotic Resistance Sales Market Share by Country (2017-2022)
Table 25. Europe Antibiotic Resistance Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Antibiotic Resistance Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Antibiotic Resistance Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Antibiotic Resistance Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Antibiotic Resistance Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Antibiotic Resistance Revenue Market Share by Region (2017-2022)
Table 31. Latin America Antibiotic Resistance Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Antibiotic Resistance Sales Market Share by Country (2017-2022)
Table 33. Latin America Antibiotic Resistance Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Antibiotic Resistance Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Antibiotic Resistance Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Antibiotic Resistance Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Antibiotic Resistance Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Antibiotic Resistance Revenue Market Share by Country (2017-2022)
Table 39. Global Antibiotic Resistance Sales by Type (2017-2022) & (K Units)
Table 40. Global Antibiotic Resistance Sales Market Share by Type (2017-2022)
Table 41. Global Antibiotic Resistance Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Antibiotic Resistance Revenue Share by Type (2017-2022)
Table 43. Global Antibiotic Resistance Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Antibiotic Resistance Sales (K Units) by Application (2017-2022)
Table 45. Global Antibiotic Resistance Sales Market Share by Application (2017-2022)
Table 46. Global Antibiotic Resistance Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Antibiotic Resistance Revenue Share by Application (2017-2022)
Table 48. Global Antibiotic Resistance Price by Application (2017-2022) & (USD/Unit)
Table 49. Allergan Corporation Information
Table 50. Allergan Description and Business Overview
Table 51. Allergan Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Allergan Antibiotic Resistance Product
Table 53. Allergan Recent Developments/Updates
Table 54. AmpliPhi Biosciences Corporation Information
Table 55. AmpliPhi Biosciences Description and Business Overview
Table 56. AmpliPhi Biosciences Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. AmpliPhi Biosciences Antibiotic Resistance Product
Table 58. AmpliPhi Biosciences Recent Developments/Updates
Table 59. BioVersys GmbH Corporation Information
Table 60. BioVersys GmbH Description and Business Overview
Table 61. BioVersys GmbH Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. BioVersys GmbH Antibiotic Resistance Product
Table 63. BioVersys GmbH Recent Developments/Updates
Table 64. Macrolide Pharmaceuticals Corporation Information
Table 65. Macrolide Pharmaceuticals Description and Business Overview
Table 66. Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Macrolide Pharmaceuticals Antibiotic Resistance Product
Table 68. Macrolide Pharmaceuticals Recent Developments/Updates
Table 69. Melinta Therapeutics Corporation Information
Table 70. Melinta Therapeutics Description and Business Overview
Table 71. Melinta Therapeutics Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Melinta Therapeutics Antibiotic Resistance Product
Table 73. Melinta Therapeutics Recent Developments/Updates
Table 74. Merck Corporation Information
Table 75. Merck Description and Business Overview
Table 76. Merck Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Merck Antibiotic Resistance Product
Table 78. Merck Recent Developments/Updates
Table 79. Nabriva Therapeutics Corporation Information
Table 80. Nabriva Therapeutics Description and Business Overview
Table 81. Nabriva Therapeutics Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Nabriva Therapeutics Antibiotic Resistance Product
Table 83. Nabriva Therapeutics Recent Developments/Updates
Table 84. Nemesis Bioscience Corporation Information
Table 85. Nemesis Bioscience Description and Business Overview
Table 86. Nemesis Bioscience Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Nemesis Bioscience Antibiotic Resistance Product
Table 88. Nemesis Bioscience Recent Developments/Updates
Table 89. Phage Technologies S.A Corporation Information
Table 90. Phage Technologies S.A Description and Business Overview
Table 91. Phage Technologies S.A Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Phage Technologies S.A Antibiotic Resistance Product
Table 93. Phage Technologies S.A Recent Developments/Updates
Table 94. Tetraphase Pharmaceuticals Corporation Information
Table 95. Tetraphase Pharmaceuticals Description and Business Overview
Table 96. Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Tetraphase Pharmaceuticals Antibiotic Resistance Product
Table 98. Tetraphase Pharmaceuticals Recent Developments/Updates
Table 99. The Medicines Company Corporation Information
Table 100. The Medicines Company Description and Business Overview
Table 101. The Medicines Company Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. The Medicines Company Antibiotic Resistance Product
Table 103. The Medicines Company Recent Developments/Updates
Table 104. TPfizer Corporation Information
Table 105. TPfizer Description and Business Overview
Table 106. TPfizer Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. TPfizer Antibiotic Resistance Product
Table 108. TPfizer Recent Developments/Updates
Table 109. Westway Health Corporation Information
Table 110. Westway Health Description and Business Overview
Table 111. Westway Health Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Westway Health Antibiotic Resistance Product
Table 113. Westway Health Recent Developments/Updates
Table 114. Production Base and Market Concentration Rate of Raw Material
Table 115. Key Suppliers of Raw Materials
Table 116. Antibiotic Resistance Distributors List
Table 117. Antibiotic Resistance Customers List
Table 118. Antibiotic Resistance Market Trends
Table 119. Antibiotic Resistance Market Drivers
Table 120. Antibiotic Resistance Market Challenges
Table 121. Antibiotic Resistance Market Restraints
Table 122. Global Antibiotic Resistance Sales Forecast by Type (2023-2028) & (K Units)
Table 123. Global Antibiotic Resistance Sales Market Share Forecast by Type (2023-2028)
Table 124. Global Antibiotic Resistance Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 125. Global Antibiotic Resistance Revenue Market Share Forecast by Type (2023-2028)
Table 126. Global Antibiotic Resistance Sales Forecast by Application (2023-2028) & (K Units)
Table 127. Global Antibiotic Resistance Sales Market Share Forecast by Application (2023-2028)
Table 128. Global Antibiotic Resistance Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 129. Global Antibiotic Resistance Revenue Market Share Forecast by Application (2023-2028)
Table 130. Global Antibiotic Resistance Sales Forecast by Region (2023-2028) & (K Units)
Table 131. Global Antibiotic Resistance Sales Market Share Forecast by Region (2023-2028)
Table 132. Global Antibiotic Resistance Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 133. Global Antibiotic Resistance Revenue Market Share Forecast by Region (2023-2028)
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antibiotic Resistance
Figure 2. Global Antibiotic Resistance Market Share by Type in 2021 & 2028
Figure 3. Product Picture
Figure 4. Product Picture
Figure 5. Global Antibiotic Resistance Market Share by Application in 2021 & 2028
Figure 6. Oxazolidinones
Figure 7. Lipoglycopeptides
Figure 8. Tetracyclines
Figure 9. Cephalosporins
Figure 10. Combination therapies
Figure 11. Other
Figure 12. Global Antibiotic Resistance Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Antibiotic Resistance Market Size (2017-2028) & (US$ Million)
Figure 14. Global Antibiotic Resistance Sales (2017-2028) & (K Units)
Figure 15. Antibiotic Resistance Sales Share by Manufacturers in 2021
Figure 16. Global Antibiotic Resistance Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Antibiotic Resistance Players: Market Share by Revenue in 2021
Figure 18. Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Antibiotic Resistance Sales Market Share by Region (2017-2022)
Figure 20. Global Antibiotic Resistance Sales Market Share by Region in 2021
Figure 21. Global Antibiotic Resistance Revenue Market Share by Region (2017-2022)
Figure 22. Global Antibiotic Resistance Revenue Market Share by Region in 2021
Figure 23. U.S. Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. U.A.E Antibiotic Resistance Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Antibiotic Resistance by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Antibiotic Resistance
Figure 49. Manufacturing Process Analysis of Antibiotic Resistance
Figure 50. Antibiotic Resistance Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan AmpliPhi Biosciences BioVersys GmbH Macrolide Pharmaceuticals Melinta Therapeutics Merck Nabriva Therapeutics Nemesis Bioscience Phage Technologies S.A Tetraphase Pharmaceuticals The Medicines Company TPfizer Westway Health